Enhanced antitumor efficacy of bile acid-lipid complex-anchored docetaxel nanoemulsion via oral metronomic scheduling

  • Jha, Saurav Kumar
  • Chung, Jee Young
  • Pangeni, Rudra
  • Choi, Hyeong Seok
  • Subedi, Laxman
  • 외 5명
Citations

WEB OF SCIENCE

37
Citations

SCOPUS

41

초록

In this study, a system for oral delivery of docetaxel (DTX) was prepared to enhance the oral absorption and anticancer efficacy of DTX via metronomic chemotherapy. DTX was complexed with low-molecular-weight methylcellulose (LMC) and loaded into a nanoemulsion (NE), yielding DTX/LMC-NE (DLNE). To further enhance the oral bioavailability, D-alpha-tocopherol polyethylene glycol succinate and sodium deoxycholate (DOCA) complexed with cationic lipid 1,2-dioleyl-3-trimethylammonium propane (DOTAP) (DOCA-DOTAP [DA-TAP] complex) was incorporated into DLNE, yielding the formulation DLNE#10. As expected, DLNE#10 showed 11.3- and 5.81-fold increases in artificial membrane (P-e) and Caco-2 permeability (P-app), respectively, resulting in 249% greater oral bioavailability, compared to free DTX. In contrast, inhibition of clathrin- and caveolamediated endocytosis, macropinocytosis, and bile acid transporters by chlorpromazine, genistein, amiloride, and actinomycin D in the Caco-2 monolayer reduced the P-app by 55.3%, 44.2%, 35.9%, and 36.5%, respectively; these findings suggest that these routes play important roles in enhancing the oral absorption of DLNE#10. In addition, our mechanistic study suggested that P-glycoprotein (P-gp) did not have an inhibitory effect on the permeation of DLNE#10. Notably, the half-maximal inhibitory concentrations (IC50) of DLNE#10 were 43.5% and 16.8% greater than those of Taxotere (R) in MCF-7 and 4T1 cells, respectively. Finally, the tumor inhibitory rates in 4T1 cell tumor-bearing mice after oral metronomic dosing of DLNE#10 (20 mg/kg DTX) were 5.02- and 1.65-fold greater than the rates in the untreated control group and intravenously injected DTX (10 mg/kg) group, respectively. These observations support the improved oral absorption and enhanced chemotherapeutic efficacy of DTX in DLNE#10 via metronomic chemotherapy, suggesting that it is a better alternative than intravenous Taxotere (R).

키워드

DocetaxelNanoemulsionBile acid transporter-mediated uptakeOral absorptionMetronomic chemotherapyVITAMIN-E-TPGSION-PAIRING COMPLEXP-GLYCOPROTEININTESTINAL-ABSORPTIONIN-VITROANTICANCER EFFICACYTRANSPORT MECHANISMDELIVERY SYSTEMSDRUGCHEMOTHERAPY
제목
Enhanced antitumor efficacy of bile acid-lipid complex-anchored docetaxel nanoemulsion via oral metronomic scheduling
저자
Jha, Saurav KumarChung, Jee YoungPangeni, RudraChoi, Hyeong SeokSubedi, LaxmanKweon, SehoChoi, Jeong UkByun, YoungroKim, Yong-HeePark, Jin Woo
DOI
10.1016/j.jconrel.2020.08.067
발행일
2020-12
유형
Article
저널명
Journal of Controlled Release
328
페이지
368 ~ 394